Free Newsletter
Ludwig Cancer Institute picks Medidata Rave
The nonprofit Ludwig Institute for Cancer Research Ltd (LICR) has chosen Medidata Rave as its electronic data capture and clinical data management solution. The Institute's clinical trials integrate laboratory and clinical research.
In the EDC selection process, LICR searched for a system that could meet the needs of complex oncology studies while linking its international research sites. The institute required a system that was intuitive and configurable, allowing staff members to build and manage their own studies, according to a Medidata announcement. It also focused on the ability to conduct frequent mid-study changes without taking the system off-line or disrupting site data input availability in any way.
With approximately 800 scientific, clinical and support staff across 10 research branches located in Australia, Brazil, Europe and the U.S., LICR conducts clinical research to translate its discoveries into applications for human benefits.
- here's the announcement
Related Articles:
Medidata lands Kitasato University as Rave implementer
Cancer center evaluates EDC solutions, picks Medidata Rave
Safety reporting tool leads Medidata to strong 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: